内镜下与开放式原位肘管松解术:655例患者的系统综述与Meta分析
该系统综述与Meta分析纳入1990至2016年发表的5项研究、共655例患者(内镜组226例,开放组429例),比较内镜下与开放式原位肘管松解术的疗效。两组在Bishop评分优良率和视觉模拟评分(VAS)降低方面无显著差异,内镜组新发瘢痕压痛/肘部疼痛发生率更低,但术后血肿发生率更高。作者认为两组总体临床改善相当,因多数研究把握度低,尚需更大样本和更长随访的进一步研究。
要点
- 内镜组与开放组在Bishop评分优良率(OR 1.27,95%CI 0.59–2.75,p=0.54)和VAS评分降低(均差-0.41,95%CI -1.49–0.67,p=0.46)方面无显著差异。
- 内镜组新发瘢痕压痛/肘部疼痛发生率更低(OR 0.19,95%CI 0.07–0.53,p=0.002)。
- 内镜组术后血肿发生率更高(OR 5.70,95%CI 1.20–27.03,p=0.03),再手术率两组分别为4.9%与4.1%(p=0.90)。
核心结论
- 作者认为内镜下与开放式原位肘管松解术在Bishop评分和VAS评分降低方面总体临床改善相当。
- 因多数研究把握度低,尚需更大样本和更长随访的进一步研究以更好明确内镜下肘管松解术的作用。
研究设计与样本
- 遵循PRISMA指南的系统综述与Meta分析,检索1990至2016年间比较内镜下与开放式肘管松解术疗效的研究。
- 纳入5项研究,共655例患者(内镜组n=226,开放组n=429)。
- 采用随机效应模型以逆方差加权进行Meta分析,计算I值用于异质性分析,并为每个分析组构建森林图。
主要发现
- 开放松解术在达到Bishop评分「优」或「良」方面无显著优势(OR 1.27,95%CI 0.59–2.75,p=0.54)。
- 开放松解术在降低VAS评分方面无显著优势(均差-0.41,95%CI -1.49–0.67,p=0.46)。
- 内镜组新发瘢痕压痛/肘部疼痛发生率更低(OR 0.19,95%CI 0.07–0.53,p=0.002)。
- 内镜组术后血肿发生率更高(OR 5.70,95%CI 1.20–27.03,p=0.03)。
- 内镜组与开放组再手术率分别为4.9%与4.1%(p=0.90)。
关键数值与推荐
- Bishop评分优良率:OR 1.27(95%CI 0.59–2.75,p=0.54)。
- VAS评分降低:均差-0.41(95%CI -1.49–0.67,p=0.46)。
- 新发瘢痕压痛/肘部疼痛:OR 0.19(95%CI 0.07–0.53,p=0.002)。
- 术后血肿:OR 5.70(95%CI 1.20–27.03,p=0.03)。
- 再手术率:内镜组4.9% vs 开放组4.1%(p=0.90)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 多数研究把握度低。
- 需要更大患者群体和更长随访的进一步研究以更好明确内镜下肘管松解术的作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cubital tunnel syndrome is the second most common peripheral entrapment syndrome. To date, there is no true consensus on the ideal surgical management. A minimally invasive, endoscopic approach has gained popularity but has not been adequately compared to the more traditional, open approach. METHODS: With compliance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, a systematic review was performed to identify studies published between 1990 and 2016 that compared the efficacy of endoscopic cubital tunnel release to open cubital tunnel release. A meta-analysis was then performed through a random-effects model with inverse variance weighting to calculate I values for heterogeneity analysis. Forest plots were constructed for each analysis group. RESULTS: Five studies involving 655 patients (endoscopic cubital tunnel release, n = 226; open cubital tunnel release, n = 429) were included. Meta-analysis revealed no significant superiority of open release in achieving an "excellent" or "good" Bishop score (OR, 1.27; 95 percent CI, 0.59 to 2.75; p = 0.54) and reduction in visual analogue scale score (mean difference, -0.41; 95 percent CI, -1.49 to 0.67; p = 0.46). However, in the endoscopic release cohort, lower rates of new-onset scar tenderness/elbow pain were found (OR, 0.19; 95 percent CI, 0.07 to 0.53; p = 0.002), but there was a higher incidence of postoperative hematomas (OR, 5.70; 95 percent CI, 1.20 to 27.03; p = 0.03). The reoperation rate in the endoscopic and open release groups was 4.9 and 4.1 percent, respectively (p = 0.90). CONCLUSIONS: The authors demonstrated equivalent overall clinical improvement between endoscopic and open cubital tunnel release in terms of Bishop score and visual analogue scale score reduction. Because of the low power of most studies, further investigations with a larger patient population and longer follow-up are needed to better characterize the role of endoscopic cubital tunnel release.
引用
- Buchanan PJ, Chieng LO, Hubbard ZS, et al. Endoscopic versus Open In Situ Cubital Tunnel Release: A Systematic Review of the Literature and Meta-Analysis of 655 Patients. Plast Reconstr Surg. 2018. PMID: 29481399. doi:10.1097/PRS.0000000000004112
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。